IL98854A - Salts derived from 62-) dialkylaminoalkylsulfonyl (papristinamycin BII and pharmaceutical preparations containing them and purification of pristinamycin BII by - Google Patents

Salts derived from 62-) dialkylaminoalkylsulfonyl (papristinamycin BII and pharmaceutical preparations containing them and purification of pristinamycin BII by

Info

Publication number
IL98854A
IL98854A IL9885491A IL9885491A IL98854A IL 98854 A IL98854 A IL 98854A IL 9885491 A IL9885491 A IL 9885491A IL 9885491 A IL9885491 A IL 9885491A IL 98854 A IL98854 A IL 98854A
Authority
IL
Israel
Prior art keywords
pristinamycin
sulphonyl
pristinamycin iib
iib
diethylaminoethyl
Prior art date
Application number
IL9885491A
Other languages
English (en)
Hebrew (he)
Other versions
IL98854A0 (en
Inventor
Cropscience Ag Bayer
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of IL98854A0 publication Critical patent/IL98854A0/xx
Publication of IL98854A publication Critical patent/IL98854A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C07K5/06182—Dipeptides with the first amino acid being heterocyclic and Pristinamycin II; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL9885491A 1990-07-16 1991-07-15 Salts derived from 62-) dialkylaminoalkylsulfonyl (papristinamycin BII and pharmaceutical preparations containing them and purification of pristinamycin BII by IL98854A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR909009037A FR2664600B1 (fr) 1990-07-16 1990-07-16 Nouveau sel derive de la dialcoylaminoalcoyl-sulfonyl-26 pristinamycine iib.

Publications (2)

Publication Number Publication Date
IL98854A0 IL98854A0 (en) 1992-07-15
IL98854A true IL98854A (en) 1995-11-27

Family

ID=9398755

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9885491A IL98854A (en) 1990-07-16 1991-07-15 Salts derived from 62-) dialkylaminoalkylsulfonyl (papristinamycin BII and pharmaceutical preparations containing them and purification of pristinamycin BII by

Country Status (20)

Country Link
US (1) US5326782A (xx)
EP (1) EP0539460B1 (xx)
JP (1) JP3345814B2 (xx)
KR (1) KR100199066B1 (xx)
AT (1) ATE112570T1 (xx)
AU (1) AU648097B2 (xx)
CA (1) CA2086925C (xx)
DE (1) DE69104485T2 (xx)
DK (1) DK0539460T3 (xx)
ES (1) ES2061259T3 (xx)
FI (1) FI100970B (xx)
FR (1) FR2664600B1 (xx)
IE (1) IE64068B1 (xx)
IL (1) IL98854A (xx)
NZ (1) NZ238949A (xx)
PT (1) PT98337B (xx)
RU (1) RU2081119C1 (xx)
TW (1) TW228523B (xx)
WO (1) WO1992001694A1 (xx)
ZA (1) ZA915445B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2664598A1 (fr) * 1990-07-16 1992-01-17 Rhone Poulenc Rorer Sa Procede de preparation de sulfinyl pristinamycine iib.
FR2766489B1 (fr) 1997-07-28 1999-08-27 Rhone Poulenc Rorer Sa Derives de streptogramines, leur preparation et les compositions qui les contiennent
US6432954B1 (en) 2000-07-14 2002-08-13 Targacept, Inc. Pharmaceutical compositions and methods for use
US6743812B1 (en) 2000-07-14 2004-06-01 Targacept, Inc. Pharmaceutical compositions and methods for use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2576022B1 (fr) * 1985-01-11 1987-09-11 Rhone Poulenc Sante Nouveaux derives de la pristinamycine ii b, leur preparation et les compositions pharmaceutiques qui les contiennent
GB8616768D0 (en) * 1986-07-09 1986-08-13 May & Baker Ltd Process
JP2552299B2 (ja) * 1987-07-07 1996-11-06 ロ−ン−プ−ラン・サント プリスチナマイシン▲ＩＩ▼в誘導体の製造法
US4931557A (en) * 1988-10-17 1990-06-05 Eli Lilly And Company Method of resolving cis 3-amino-4-(2-furyl)vinyl)-1-methoxycarbonylmethyl-azetidin-2-one and di-p-toluoyl-tartaric acid salts thereof

Also Published As

Publication number Publication date
EP0539460A1 (fr) 1993-05-05
DK0539460T3 (da) 1994-11-07
IE64068B1 (en) 1995-07-12
JPH05508652A (ja) 1993-12-02
RU2081119C1 (ru) 1997-06-10
FR2664600A1 (fr) 1992-01-17
CA2086925C (fr) 2002-12-10
KR100199066B1 (ko) 1999-06-15
FR2664600B1 (fr) 1994-09-02
FI930166A (fi) 1993-01-15
TW228523B (xx) 1994-08-21
KR930701451A (ko) 1993-06-11
CA2086925A1 (fr) 1992-01-17
JP3345814B2 (ja) 2002-11-18
PT98337A (pt) 1992-05-29
ATE112570T1 (de) 1994-10-15
DE69104485D1 (de) 1994-11-10
WO1992001694A1 (fr) 1992-02-06
NZ238949A (en) 1992-09-25
US5326782A (en) 1994-07-05
ES2061259T3 (es) 1994-12-01
PT98337B (pt) 1999-01-29
IE912448A1 (en) 1992-01-29
DE69104485T2 (de) 1995-02-23
ZA915445B (en) 1992-04-29
IL98854A0 (en) 1992-07-15
FI100970B (fi) 1998-03-31
AU648097B2 (en) 1994-04-14
EP0539460B1 (fr) 1994-10-05
AU8223991A (en) 1992-02-18
FI930166A0 (fi) 1993-01-15

Similar Documents

Publication Publication Date Title
CA1230113A (en) Method for producing chemical compounds
EP0092968B1 (en) Crystalline benzenesulfonate salts of sultamicillin
AU703634B2 (en) Novel crystalline forms of anhydrous 7-{(1alpha,5alpha, 6alpha)-6-amino-3-azabicyclo(3.1.0)hex-3-y1}-6-fluoro-1- (2,4-difluorophenyl)-1,4-dihydro-4-oxo-1,8-naphthyridine-3- carboxylic acid, methanesulfonic acid salt.
CZ471190A3 (cs) Inhibitory retrovirálních proteáz
GB2116542A (en) Tetrahydroisoquinoline-3- carboxylic acids
US5223488A (en) Oxidized-type glutathione alkyl ester
CN103108865A (zh) 方法和中间体
IE52717B1 (en) Novel indanyl derivatives and their manufacture and use
JP2000505438A (ja) 抗生物質ＧＥ２２７０因子Ｃ▲下２ａ▼、Ｄ▲下２▼およびＥの誘導体
IL98854A (en) Salts derived from 62-) dialkylaminoalkylsulfonyl (papristinamycin BII and pharmaceutical preparations containing them and purification of pristinamycin BII by
JPH0363289A (ja) 抗生物質ｇｅ２２７０因子ａ↓１、ａ↓２、ａ↓３およびｈ
JPH10504040A (ja) Ｇｅ２２７０及びｇｅ２２７０−様抗生物質の塩基性プロリン−アミド誘導体
JPH03112933A (ja) 抗腫瘍剤
JP4277015B2 (ja) ストレプトグラミン誘導体、その製造およびそれを含む製薬組成物
GB2206879A (en) Novel pristinamycin IIB derivatives, their preparation and pharmaceutical compositions containing them
IE57632B1 (en) Azahomoerythromycin b derivatives and intermediates therefor
CZ290550B6 (cs) Krystalický (+) L-hydrogenvinan 3-(4-hexyloxy-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyridinu, způsob jeho přípravy, farmaceutický prostředek jej obsahující a jeho pouľití
AU704115B2 (en) Zwitterionic forms of trovafloxacin
EP0831092B1 (en) Hydroquinone derivative and pharmaceutical use thereof
EP0237248A2 (en) 2-[(2-Pyridyl)methylsulfinyl]thienoimidazoles and related compounds as antiulcer agents
GB2199033A (en) 3s(z)-21-(2-amino-4-thiazolyl)-2-2,2-dimethyl-4-oxo-1-1(sulfooxy)-3-azetidinylamino-2-oxoethylidene-aminooxyacetic acids salts
JPH04235187A (ja) ３４−デ（アセチルグルコサミニル）−３４−デオキシ−テイコプラニンのｃ６３−アミン誘導体およびグリコペプチドの抗生物質に対して抵抗性のバクテリアに対する薬物としてのそれらの使用
WO1997008191A1 (en) Polymorphs of the prodrug 6-n-(l-ala-l-ala)-trovafloxacin
JPH05117280A (ja) アミノ酸置換チアゼトキノリン−３−カルボン酸誘導体
JPH0144169B2 (xx)

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired